News
DURING SCREENING SEASON, which runs from March to December, LUCAS sets off on Mondays from the cancer institute in Morgantown ...
Medical experts report rising lung cancer diagnoses in non-smokers as smoking rates decline, raising questions about ...
U.S. drugmaker Merck is nearing a deal worth about $10 billion to buy Verona Pharma, a company focused on therapies for lung ...
Australia has launched its first lung cancer screening program, which targets current and recent smokers with biennial ...
An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.
Corticosteroids are commonly prescribed to alleviate cancer-related symptoms in patients with non-small cell lung cancer, ...
The primary measure of ILD progression was a decline in forced vital capacity (FVC) of 5% or more between annual visits.
Company’s New Groundbreaking Preclinical Data in NSCLC Models Provides Further Validation for SIL204's Innovative Delivery ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results